PembrolizumabSkin rash: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1759卷 / 1期

关键词：

D O I：

10.1007/s40278-019-64099-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：209 / 209

相关论文

共 50 条

[1] PembrolizumabSkin rash: case report
Reactions Weekly, 2019, 1774 (1) : 264 - 264
[2] PembrolizumabSkin rash and liver dysfunction: case report
Reactions Weekly, 2020, 1803 (1) : 199 - 199
[3] Ipilimumab/nivolumab/pembrolizumabSkin rash and vitiligo: 2 case reports
Reactions Weekly, 2019, 1776 (1) : 248 - 248
[4] PembrolizumabSkin rashes: case report
Reactions Weekly, 2017, 1649 (1) : 206 - 206
[5] Nivolumab/pembrolizumabSkin rash, acute kidney injury and immune complex-mediated glomerulonephritis: case report
Reactions Weekly, 2019, 1744 (1) : 205 - 205
[6] PembrolizumabSkin toxicity and perforated appendicitis: case report
Reactions Weekly, 2024, 2039 (1) : 467 - 467
[7] PembrolizumabSkin toxicity, grade 2 hepatotoxicity, and renal toxicity: case report
Reactions Weekly, 2024, 2022 (1) : 233 - 233
[8] CarbamazepineSkin rash: case report
Reactions Weekly, 2013, 1467 (1) : 10 - 10
[9] AzathioprineSkin rash: case report
Reactions Weekly, 2019, 1770 (1) : 72 - 72
[10] NevirapineDiffused rash: case report
Reactions Weekly, 2025, 2045 (1) : 328 - 328

← 1 2 3 4 5 →